“We will Consider how the commercialization of the substance fits in with our business product at Adastra in order to situation ourselves to guidance the desire for a secure source of copyright,” said Main executive officer Michael Forbes inside a information release. The company explained to VICE News it wouldn't be commenting even more.Some i